Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.
about
Severe infectious diseases of childhood as monogenic inborn errors of immunityInnate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune CellsIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityBacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesIL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionEnhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndromeCompartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosisInduction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective studyIL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and TurkeyMolecular analysis of idiopathic subglottic stenosis for Mycobacterium species.The TB pandemic: an old problem seeking new solutions.A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease.Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese.Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonellaInterferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosisHuman and animal infections with Mycobacterium microti, ScotlandClinical disease caused by Klebsiella in 2 unrelated patients with interleukin 12 receptor beta1 deficiency.Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency.Interleukin-12 receptor β1 deficiency predisposing to disseminated CoccidioidomycosisGenetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.CD4 T cells: fates, functions, and faultsRevisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries.IL12Rβ1: the cytokine receptor that we used to know.Knowledge gaining by human genetic studies on tuberculosis susceptibility.Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy.Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease.A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases.When the Fight against Fungi Goes WrongA patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome.Defects in the interferon-gamma and interleukin-12 pathways.The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
P2860
Q26775891-3EFEBB56-1767-4793-B8BC-1C54F92E759BQ26799901-BBAA85DE-3A71-4BF1-AFD0-1ABA1344339EQ26830943-CCBCFA08-4DA1-4E84-AA14-FDC5CF0360A8Q26862947-26A276E1-72B3-49B9-8EAF-C820429AEC10Q26863260-D004B25D-8384-4ADD-BC1E-3A6B47FB7472Q27022796-DAA33E85-FDA3-435F-8A3B-14C1F8EA0511Q28070339-636B4BF9-587C-48E4-8CD5-C6B7C058907EQ28084489-79E63F1B-2DC5-4851-9C2C-04B4EFE762BBQ28266613-0AA4A5F6-0F2C-4D43-A6FD-FF8B5165FA4DQ28387743-12CDE4F5-2BCE-4B05-BF81-3A37A4BCCA1CQ28538654-5E31B4E6-F976-4EB8-A208-EC59F994E8DDQ28741093-8297FA56-81FD-4124-AE56-A8792C1E5954Q30276624-40E2736B-9DB5-4F2A-8701-3DCF4AFB210BQ30360726-9D562A05-1CBF-4048-BC5D-AF6B92FB36A9Q30492620-C4D2AA33-7358-4C5E-842F-67DF933C6271Q30839566-2F8B69F9-BE0F-4662-8F35-058E9A9C3986Q30850932-2CDD64B2-4502-46C1-B5C8-5BC644E9C528Q33255341-136C9431-578C-4BFB-BACE-2B3A524C0FE0Q33334439-7BC712AB-03D0-43D3-8AEA-6F6E7E6C6B12Q33588166-26873957-E448-45EA-8B81-C91F2E0D2F08Q33596687-2CE0B697-F7D8-4E59-9D3C-7B2314EF1311Q33877758-142BF1EB-7746-427E-A536-1A526068AA96Q34421458-2EFE24B5-3106-43FB-8C6D-7992D28B0C33Q34460558-302682C4-3B7C-4ACB-8638-A1DEB9D36527Q34699215-09C88DBB-41DB-43FD-99B9-71757282E4B4Q34785970-24204D88-DD68-4F0D-810E-B176518E83D2Q34809934-B273A491-259E-47B7-8E63-6830A1722F8DQ34813153-87035B2C-66A2-494E-BB5F-3757C73AE515Q35086274-9C43A26D-F3CF-4E2C-AFE3-AF35EB8F1CB8Q35136546-BAC6574D-A9F9-4040-BA63-7DEEEA40254EQ35202903-F1E67503-BCFA-4B59-A1B4-BD7E7A030EE8Q35284909-283409AB-5092-4DFB-968C-8203AC637BBBQ35540935-FD65EB25-740B-42BB-9E11-00D8242B5449Q35624686-AE01A88C-FF3B-4E56-9E44-8B81DADEC3D5Q35860015-4915F4F1-63BC-4F3B-B4E4-6F28D859F19DQ35914364-376B9A46-3E64-4BDF-8862-73F7F8F0A1F0Q35989593-4CA8ED42-3630-41DA-AAC1-88AD51235C12Q36015012-26C169BE-1D21-46EC-97B0-AA3284FEF909Q36090400-E0FA7088-10C5-4B6C-8A5B-8534B37CBF91Q36184396-3324D345-3E0B-4C1A-95FD-17DAEB9E7D60
P2860
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Low penetrance, broad resistan ...... nd immunological implications.
@ast
Low penetrance, broad resistan ...... nd immunological implications.
@en
type
label
Low penetrance, broad resistan ...... nd immunological implications.
@ast
Low penetrance, broad resistan ...... nd immunological implications.
@en
prefLabel
Low penetrance, broad resistan ...... nd immunological implications.
@ast
Low penetrance, broad resistan ...... nd immunological implications.
@en
P2093
P2860
P50
P356
P1476
Low penetrance, broad resistan ...... nd immunological implications.
@en
P2093
Adrien Breiman
Aileen M Cleary
Alberto José Da Silva Duarte
Andrea Enright
Carlos Rodriguez-Gallego
Christiane Vermylen
Claire Fieschi
David Lammas
David Nadal
David Tuerlinckx
P2860
P304
P356
10.1084/JEM.20021769
P407
P50
P577
2003-02-01T00:00:00Z